News Daily News The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead Michael O'Riordan June 20, 2024
News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Daily News Label for Impella RP Flex Catheters Recalled to Address Anticoagulant Confusion: FDA Caitlin E. Cox August 18, 2023
News Conference News ACC 2023 How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA Todd Neale March 09, 2023
News Conference News THT 2022 LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety Caitlin E. Cox February 02, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022
News Daily News Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF Michael O'Riordan April 15, 2021
News Daily News Safe to Upgrade From Pacemaker or Defibrillator to CRT Michael O'Riordan February 10, 2021
News Conference News HFSA 2020 Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study L.A. McKeown October 12, 2020
News Daily News COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death L.A. McKeown July 23, 2020
News Daily News Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians Caitlin E. Cox April 09, 2020
News Daily News Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF L.A. McKeown November 02, 2018
News Conference News AHA 2017 Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I Michael O'Riordan November 21, 2017